Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions
This study has been completed.
Study NCT00654277 Information provided by Par Pharmaceutical, Inc.
First Received on April 3, 2008. Last Updated on April 10, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Physiological Effects of Drugs
Sponsors listed in this trial
Par Pharmaceutical, Inc.
Algorithme Pharma Inc
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers